Skip to content

Mel 80

by Carl Zeiss Meditec AG

Ref 1429-382

Mel 80 is an ophthalmic excimer laser system (EU MDD Class IIb; FDA Class III; FDA product code LZS, Excimer Laser System) made by Carl Zeiss Meditec AG, registered in EUDAMED on 23 Jul 2026 (Basic UDI-DI B-04049471000221), approved under FDA PMA P060004 on 11 Aug 2006 and listed in FDA GUDID since 3 Sep 2014 (UDI-DI 04049471000221), active as of 23 Oct 2026.

Active European Union and United States. Also listed in GUDID (US).

CE MDD PMA

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

PMA P060004

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD EUDAMED NumberB-04049471000221 Basic UDI-DI 04049471000221UDI-DIDate23 Jul 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number04049471000221 UDI-DI Date3 Sep 2014ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR GUDID from GUDID Approved NumberP060004 Date11 Aug 2006DecidedStatusActive

Official records

From the FDA record

Device description
The MEL 80 Excimer Laser System is indicated for use in primary Laser Assisted in situ Keratomileusis (LASIK) treatments for the reduction or elimination of - myopia of less than or equal to -7.0 D with or without refractive astigmatism of less than or equal to -3.0 D, with a Maximum MRSE of -7.0 D - naturally occurring hyperopia of less than or equal to +5.0 D with or without refractive astigmatism of greater than +0.5 D and less than or equal to +3.0 D, with a maximum MRSE of +5.0 D in patients who are 21 years of age or older with documentation of stable manifest refraction over the past year as demonstrated by Change in sphere and cylinder of 0.5 D.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-04049471000221 registered 23 Jul 2026 Active
  • FDA PMA P060004 decided 11 Aug 2006 Active
  • FDA GUDID UDI-DI 04049471000221 listed 3 Sep 2014 Listed

Timeline

3 dated events

  1. Approved FDA PMA P060004
  2. Listed FDA GUDID 04049471000221
  3. Registered EUDAMED B-04049471000221

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDD Active
  • United States FDA PMA Active

Specification

EUDAMED · GUDID

Generic name
Ophthalmic excimer laser system
Model / reference
1429-382 EUDAMED
MEL 80 GUDID
Primary DI / UDI-DI
04049471000221
Basic UDI-DI
B-04049471000221
PMA number
FDA product code
LZS
EMDN code
Z12120203 Corneal miller
GMDN term
Ophthalmic excimer laser system
Device class
Class IIb EUDAMED
Class III GUDID
EU registration type
Legacy device (under a directive)
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution
Size
Weight — 260 Kilogram

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Model / referenceEUDAMED
1429-382
GUDID
MEL 80
Device classEUDAMED
Class IIb
GUDID
Class III

Device class is stated on each registry's own scale: Class IIb in the EU (EUDAMED), Class III in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under THERAPEUTIC AND SURGICAL OPHTHOLMOLOGICAL TREATMENTS INSTRUMENTS.

Other devices from Carl Zeiss Meditec AG

See all devices from Carl Zeiss Meditec AG →

Properties

  • Serial number
  • Manufacturing date
Other properties (23, all answered No)